Thrombotic microangiopathies: multimers, metalloprotease, and beyond
| Autor: | Joel Moake |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Thrombotic thrombocytopenic purpura
ADAMTS13 Protein Angiogenesis Inhibitors Antineoplastic Agents Bioinformatics Models Biological General Biochemistry Genetics and Molecular Biology Preeclampsia Platelet Adhesiveness Liver enzyme hemic and lymphatic diseases von Willebrand Factor medicine Thrombotic Microangiopathies Humans General Pharmacology Toxicology and Pharmaceutics Research Articles Metalloproteinase Purpura Thrombotic Thrombocytopenic business.industry General Neuroscience General Medicine medicine.disease Low platelets Protein Structure Tertiary ADAM Proteins Hemolytic-Uremic Syndrome Metalloproteases business Immunosuppressive Agents |
| Zdroj: | Clinical and translational science. 2(5) |
| ISSN: | 1752-8062 |
| Popis: | The pathophysiology of various types of thrombotic microangiopathies is coming progressively into focus. Therapeutic advances are likely to follow at a quickening pace. This discussion focuses on thrombotic thrombocytopenic purpura (TTP), the hemolytic-uremic syndrome (HUS), thrombotic microangiopathies associated with transplantation-immunosuppression or anti-angiogenesis therapy, and the preeclampsia/hemolysis-elevated liver enzymes and low platelets syndrome (HELLP). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text